Skip to content

Clinical trials

Myeloproliferative Disorders trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: Russia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20112
20132
20143
20151
20161
20191
20214
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Petersburg State Pavlov Medical University5
Novartis Pharmaceuticals4
AOP Orphan Pharmaceuticals AG2
CTI BioPharma2
Celgene2
Geron Corporation1
Janssen-Cilag International NV1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders18
Myelodysplastic Syndromes7
Bone Marrow Diseases6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Primary Myelofibrosis6
Hematologic Diseases5
Leukemia, Myeloid, Acute5
Anemia4
Polycythemia Vera3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.